Last update:

Clinical pharmacology news

Glucosamine supplements may speed memory loss from Alzheimer's, new research shows

People with Alzheimer's disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn't. That's the key finding of a new study that my colleagues and I published in the ...

Key mechanism regulating the anti-inflammatory function of extracellular vesicles identified

A study led by the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) group at the Germans Trias i Pujol Research Institute (IGTP) has identified a key mechanism regulating the anti-inflammatory function ...

Engineers find a way to deliver drugs directly to the esophagus

There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part of the body is difficult, so patients are usually treated with systemic drugs, which can have unwanted ...

Why the liquid you take with your medication matters

Some alkaline mineral and medicinal waters may weaken the enteric coating of medications within just a few minutes, potentially reducing their effectiveness, according to a new study by Semmelweis University. The study, published ...

A popular joint pain supplement may accelerate dementia

New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer's disease. The ...